295 related articles for article (PubMed ID: 24311376)
1. Erythrocyte-derived microvesicles amplify systemic inflammation by thrombin-dependent activation of complement.
Zecher D; Cumpelik A; Schifferli JA
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):313-20. PubMed ID: 24311376
[TBL] [Abstract][Full Text] [Related]
2. Platelet-derived microparticles regulates thrombin generation via phophatidylserine in abdominal sepsis.
Wang Y; Zhang S; Luo L; Norström E; Braun OÖ; Mörgelin M; Thorlacius H
J Cell Physiol; 2018 Feb; 233(2):1051-1060. PubMed ID: 28409836
[TBL] [Abstract][Full Text] [Related]
3. Elevated levels of thrombin-generating microparticles in stored red blood cells.
Gao Y; Lv L; Liu S; Ma G; Su Y
Vox Sang; 2013 Jul; 105(1):11-7. PubMed ID: 23347295
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil microvesicles resolve gout by inhibiting C5a-mediated priming of the inflammasome.
Cumpelik A; Ankli B; Zecher D; Schifferli JA
Ann Rheum Dis; 2016 Jun; 75(6):1236-45. PubMed ID: 26245757
[TBL] [Abstract][Full Text] [Related]
5. Thrombin-activatable fibrinolysis inhibitor protects against acute lung injury by inhibiting the complement system.
Naito M; Taguchi O; Kobayashi T; Takagi T; D'Alessandro-Gabazza CN; Matsushima Y; Boveda-Ruiz D; Gil-Bernabe P; Matsumoto T; Chelakkot-Govindalayathil AL; Toda M; Yasukawa A; Hataji O; Morser J; Takei Y; Gabazza EC
Am J Respir Cell Mol Biol; 2013 Oct; 49(4):646-53. PubMed ID: 23721130
[TBL] [Abstract][Full Text] [Related]
6. Complement Interactions with Blood Cells, Endothelial Cells and Microvesicles in Thrombotic and Inflammatory Conditions.
Karpman D; Ståhl AL; Arvidsson I; Johansson K; Loos S; Tati R; Békássy Z; Kristoffersson AC; Mossberg M; Kahn R
Adv Exp Med Biol; 2015; 865():19-42. PubMed ID: 26306441
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effect of thrombin and CD40 ligand on endothelial matrix metalloproteinase-10 expression and microparticle generation in vitro and in vivo.
Martínez de Lizarrondo S; Roncal C; Calvayrac O; Rodríguez C; Varo N; Purroy A; Lorente L; Rodríguez JA; Doeuvre L; Hervás-Stubbs S; Angles-Cano E; Páramo JA; Martínez-González J; Orbe J
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1477-87. PubMed ID: 22492089
[TBL] [Abstract][Full Text] [Related]
8. Epithelial and Erythrocyte Microvesicles From Bronchoalveolar Lavage Fluid Are Elevated and Associated With Outcome in Chronic Lung Allograft Dysfunction.
Harms A; Fuehner T; Warnecke G; Haverich A; Gottlieb J; Trummer A
Transplantation; 2015 Nov; 99(11):2394-400. PubMed ID: 26451527
[TBL] [Abstract][Full Text] [Related]
9. Intravascular hemolysis activates complement via cell-free heme and heme-loaded microvesicles.
Merle NS; Grunenwald A; Rajaratnam H; Gnemmi V; Frimat M; Figueres ML; Knockaert S; Bouzekri S; Charue D; Noe R; Robe-Rybkine T; Le-Hoang M; Brinkman N; Gentinetta T; Edler M; Petrillo S; Tolosano E; Miescher S; Le Jeune S; Houillier P; Chauvet S; Rabant M; Dimitrov JD; Fremeaux-Bacchi V; Blanc-Brude OP; Roumenina LT
JCI Insight; 2018 Jun; 3(12):. PubMed ID: 29925688
[TBL] [Abstract][Full Text] [Related]
10. Biphasic clearance of incompatible red blood cells through a novel mechanism requiring neither complement nor Fcγ receptors in a murine model.
Liepkalns JS; Hod EA; Stowell SR; Cadwell CM; Spitalnik SL; Zimring JC
Transfusion; 2012 Dec; 52(12):2631-45. PubMed ID: 22502635
[TBL] [Abstract][Full Text] [Related]
11. The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles.
Gerotziafas GT; Van Dreden P; Chaari M; Galea V; Khaterchi A; Lionnet F; Stankovic-Stojanovic K; Blanc-Brude O; Woodhams B; Maier-Redelsperger M; Girot R; Hatmi M; Elalamy I
Thromb Haemost; 2012 Jun; 107(6):1044-52. PubMed ID: 22535498
[TBL] [Abstract][Full Text] [Related]
12. Generation of C5a in the absence of C3: a new complement activation pathway.
Huber-Lang M; Sarma JV; Zetoune FS; Rittirsch D; Neff TA; McGuire SR; Lambris JD; Warner RL; Flierl MA; Hoesel LM; Gebhard F; Younger JG; Drouin SM; Wetsel RA; Ward PA
Nat Med; 2006 Jun; 12(6):682-7. PubMed ID: 16715088
[TBL] [Abstract][Full Text] [Related]
13. Complement Component 3 Negatively Regulates Antibody Response by Modulation of Red Blood Cell Antigen.
Mener A; Arthur CM; Patel SR; Liu J; Hendrickson JE; Stowell SR
Front Immunol; 2018; 9():676. PubMed ID: 29942300
[TBL] [Abstract][Full Text] [Related]
14. Microparticles formed during storage of red blood cell units support thrombin generation.
Bouchard BA; Orfeo T; Keith HN; Lavoie EM; Gissel M; Fung M; Mann KG
J Trauma Acute Care Surg; 2018 Apr; 84(4):598-605. PubMed ID: 29251713
[TBL] [Abstract][Full Text] [Related]
15. Supernatants from stored red blood cell (RBC) units, but not RBC-derived microvesicles, suppress monocyte function in vitro.
Muszynski JA; Bale J; Nateri J; Nicol K; Wang Y; Wright V; Marsh CB; Gavrilin MA; Sarkar A; Wewers MD; Hall MW
Transfusion; 2015 Aug; 55(8):1937-45. PubMed ID: 25819532
[TBL] [Abstract][Full Text] [Related]
16. Tumor-derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine-dependent manner.
Lima LG; Chammas R; Monteiro RQ; Moreira ME; Barcinski MA
Cancer Lett; 2009 Oct; 283(2):168-75. PubMed ID: 19401262
[TBL] [Abstract][Full Text] [Related]
17. Polyglycolic acid-induced inflammation: role of hydrolysis and resulting complement activation.
Ceonzo K; Gaynor A; Shaffer L; Kojima K; Vacanti CA; Stahl GL
Tissue Eng; 2006 Feb; 12(2):301-8. PubMed ID: 16548688
[TBL] [Abstract][Full Text] [Related]
18. Red blood cell microvesicles activate the contact system, leading to factor IX activation via 2 independent pathways.
Noubouossie DF; Henderson MW; Mooberry M; Ilich A; Ellsworth P; Piegore M; Skinner SC; Pawlinski R; Welsby I; Renné T; Hoffman M; Monroe DM; Key NS
Blood; 2020 Mar; 135(10):755-765. PubMed ID: 31971571
[TBL] [Abstract][Full Text] [Related]
19. Complement C5a Induces Pro-inflammatory Microvesicle Shedding in Severely Injured Patients.
Karasu E; Demmelmaier J; Kellermann S; Holzmann K; Köhl J; Schmidt CQ; Kalbitz M; Gebhard F; Huber-Lang MS; Halbgebauer R
Front Immunol; 2020; 11():1789. PubMed ID: 32983087
[TBL] [Abstract][Full Text] [Related]
20. C5 inhibition prevents renal failure in a mouse model of lethal C3 glomerulopathy.
Williams AL; Gullipalli D; Ueda Y; Sato S; Zhou L; Miwa T; Tung KS; Song WC
Kidney Int; 2017 Jun; 91(6):1386-1397. PubMed ID: 28139294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
